NasdaqGS - Nasdaq Real Time Price USD
Amneal Pharmaceuticals, Inc. (AMRX)
7.20
-0.01
(-0.21%)
As of 11:43:20 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 3,143,782 | 19 |
| Sales | 5,822,808 | 13 |
| Net Shares Purchased (Sold) | -2,679,026 | 32 |
| Total Insider Shares Held | 146.53M | -- |
| % Net Shares Purchased (Sold) | -1.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SHAH NIKITA Officer | Sale at price 7.58 per share. | Direct | 372,481 | May 16, 2025 |
| KIELY JOHN J. Director | Sale at price 7.59 per share. | Direct | 379,500 | May 12, 2025 |
| BUCHI J. KEVIN Director | -- | Direct | -- | May 5, 2025 |
| ALVA EMILY PETERSON Director | -- | Direct | -- | May 5, 2025 |
| PATEL GAUTAM Director | -- | Direct | -- | May 5, 2025 |
| KIELY JOHN J. Director | -- | Direct | -- | May 5, 2025 |
| GEORGE JEFFREY P. Director | -- | Direct | -- | May 5, 2025 |
| AUTOR DEBORAH M Director | -- | Direct | -- | May 5, 2025 |
| MEISTER PAUL M Director | -- | Direct | -- | May 5, 2025 |
| NARK THEODORE C. Director | -- | Direct | -- | May 5, 2025 |
| YANAI SHLOMO Director | -- | Direct | -- | May 5, 2025 |
| PATEL GAUTAM Director | Sale at price 8.00 per share. | Direct | 69,344 | May 5, 2025 |
| PATEL GAUTAM Director | Sale at price 8.30 per share. | Direct | 664,000 | Apr 1, 2025 |
| PATEL TUSHAR BHIKHUBHAI Beneficial Owner of more than 10% of a Class of Security | Sale at price 8.35 per share. | Indirect | 41,750,000 | Mar 14, 2025 |
| BUCHI J. KEVIN Director | Stock Gift at price 0.00 per share. | Direct | 0 | Mar 10, 2025 |
| DALY JASON B. Officer | Sale at price 8.73 - 8.88 per share. | Direct | 792,160 | Mar 6, 2025 |
| BOYER ANDREW S Officer | Sale at price 8.89 per share. | Direct | 1,111,250 | Mar 5, 2025 |
| ALVA EMILY PETERSON Director | Sale at price 8.90 per share. | Direct | 712,000 | Mar 5, 2025 |
| KONIDARIS TASOS Chief Financial Officer | Sale at price 8.91 per share. | Direct | 891,000 | Mar 5, 2025 |
| SHAH NIKITA Officer | -- | Direct | -- | Mar 4, 2025 |
| PATEL CHINTU Chief Executive Officer | -- | Direct | -- | Mar 4, 2025 |
| DALY JASON B. Officer | -- | Direct | -- | Mar 4, 2025 |
| KONIDARIS TASOS Chief Financial Officer | -- | Direct | -- | Mar 4, 2025 |
| BOYER ANDREW S Officer | -- | Direct | -- | Mar 4, 2025 |
| PATEL CHIRAG K Chief Executive Officer | -- | Direct | -- | Mar 4, 2025 |
| PATEL GAUTAM Director | Sale at price 8.90 per share. | Direct | 712,000 | Mar 3, 2025 |
| SHAH NIKITA Officer | -- | Direct | -- | Feb 28, 2025 |
| KONIDARIS TASOS Chief Financial Officer | -- | Direct | -- | Feb 28, 2025 |
| BOYER ANDREW S Officer | -- | Direct | -- | Feb 28, 2025 |
| PATEL GAUTAM Director | Sale at price 8.14 per share. | Direct | 651,200 | Feb 3, 2025 |
| PATEL GAUTAM Director | Sale at price 8.01 per share. | Direct | 501,346 | Jan 8, 2025 |
| PATEL GAUTAM Director | Sale at price 8.01 per share. | Direct | 139,454 | Jan 2, 2025 |
| KIELY JOHN J. Director | Conversion of Exercise of derivative security at price 4.76 per share. | Direct | 135,689 | Nov 22, 2024 |
| KIELY JOHN J. Director | Sale at price 8.38 per share. | Direct | 142,946 | Nov 22, 2024 |
| AUTOR DEBORAH M Director | Sale at price 8.34 - 8.41 per share. | Direct | 334,074 | Nov 22, 2024 |
| DALY JASON B. Officer | Sale at price 8.40 per share. | Direct | 114,786 | Nov 21, 2024 |
| DALY JASON B. Officer | Sale at price 8.61 per share. | Direct | 375,887 | Nov 15, 2024 |
| BOYER ANDREW S Officer | Sale at price 7.81 - 7.85 per share. | Direct | 491,382 | Aug 15, 2024 |
| SHAH NIKITA Officer | Sale at price 7.75 per share. | Direct | 775,000 | Aug 14, 2024 |
| AUTOR DEBORAH M Director | Sale at price 6.73 - 6.76 per share. | Direct | 256,106 | May 17, 2024 |
| BUCHI J. KEVIN Director | -- | Direct | -- | May 10, 2024 |
| ALVA EMILY PETERSON Director | -- | Direct | -- | May 10, 2024 |
| PATEL GAUTAM Director | -- | Direct | -- | May 10, 2024 |
| KIELY JOHN J. Director | -- | Direct | -- | May 10, 2024 |
| GEORGE JEFFREY P. Director | -- | Direct | -- | May 10, 2024 |
| AUTOR DEBORAH M Director | -- | Direct | -- | May 10, 2024 |
| MEISTER PAUL M Director | -- | Direct | -- | May 10, 2024 |
| NARK THEODORE C. Director | -- | Direct | -- | May 10, 2024 |
| YANAI SHLOMO Director | -- | Direct | -- | May 10, 2024 |
| KONIDARIS TASOS Chief Financial Officer | -- | Direct | -- | Mar 12, 2024 |
Related Tickers
RDY Dr. Reddy's Laboratories Limited
15.57
+5.59%
CPIX Cumberland Pharmaceuticals Inc.
5.45
-1.45%
LFCR Lifecore Biomedical, Inc.
6.83
-0.80%
HLN Haleon plc
11.09
+1.37%
COLL Collegium Pharmaceutical, Inc.
29.32
-0.27%
HCM HUTCHMED (China) Limited
15.17
-0.85%
DVAX Dynavax Technologies Corporation
9.95
+0.56%
PRGO Perrigo Company plc
26.13
-0.46%
ANIK Anika Therapeutics, Inc.
11.46
-1.63%
TAK Takeda Pharmaceutical Company Limited
14.95
-0.53%